Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AAS +AED AKW ARJ BHG BIC CFY CNC CNH CNR CPK CPN EIM FGF GIA GRP HWE HZL ION IPA MAE MCO MYA NER BGC NLG ONL PTN QMG RLG SNR SRA STI CR3 LGR VGP VIP ZHE | Ann: ASX Market Release - Suspension | 15/11/12 | 43 | 78K | |||
|
|||||||
AAS +CNC CNH CPK HZL NLG ONL PTN QMG RLG ZHE | Ann: ASX Market Release - Removal from Official L | 09:51 | 0 | 2.7K | |||
|
|||||||
CNH | Ann: ASIC Form 484 - Capital Reduction | 06/08/12 | 1 | 1.8K | |||
|
|||||||
CNH | Ann: Acquisition and Re-admission - Update | 23/03/12 | 0 | 1.3K | |||
|
|||||||
CNH | Ann: Capital Reduction and Cancellation | 21/03/12 | 0 | 1.3K | |||
|
|||||||
CNH | Ann: Results of Annual General Meeting | 07/03/12 | 0 | 1.0K | |||
|
|||||||
CNH | Ann: Results of Special Meeting | 07/03/12 | 0 | 1.0K | |||
|
|||||||
CNH | Ann: Results of General Meeting | 07/03/12 | 0 | 1.0K | |||
|
See All Discussions